Items with full text/Total items : 90069/105176 (86%)
Visitors : 6367033
Online Users : 441
Please use this identifier to cite or link to this item:
|Title: ||Amphiregulin Promotes Vascular Endothelial Growth Factor-C Expression and Lymphangiogenesis through STAT3 Activation in Human Chondrosarcoma Cells.|
|Authors: ||Huang, Yu-Wen;Huang, Yu-Wen;Ts, Hsiao-Chi;Tsai, Hsiao-Chi;Wan, Shih-Wei;Wang, Shih-Wei;Kuo, Shu-Jui;Kuo, Shu-Jui;Fong, Yi-Chin;Fong, Yi-Chin;湯智昕;Chih-Hsin;Tang|
|Issue Date: ||2019-09-18 11:01:43 (UTC+8)|
Chondrosarcoma is the second most common primary malignancy of bone, characterized by a high metastatic potential. Increasing clinical data highlight the important role played by lymphangiogenesis in cancer metastasis. Amphiregulin (AR) has been implicated in tumor metastasis and lymphangiogenesis, but its association with vascular endothelial growth factor-C (VEGF-C) expression and lymphangiogenesis in chondrosarcoma is unclear.
We used qPCR, ELISA and Western blotting to detect AR-induced VEGF-C expression in chondrosarcoma cells. Lymphangiogenesis was investigated by lymphatic endothelial cells (LECs) migration and tube formation. An in vivo experiment examined AR expression in tumor-associated lymphangiogenesis.
In this study, we found that both AR and VEGF-C expression correlated with tumor stage and were significantly higher than levels found in normal cartilage. Exogenous AR promoted VEGF-C expression in chondrosarcoma cells in a time- and dose-dependent manner and subsequently increased migration and tube formation of LECs. AR also increased VEGF-C expression and lymphangiogenesis through the Src/MEK/ERK/STAT3 signaling pathway. However, it is unclear as to how an EGFR ligand (AR) induces activation of the Src kinase. Knockdown of AR decreased VEGF-C expression in chondrosarcoma cells. Similarly, lymphangiogenesis was abolished in AR knockdown cells in an in vivo model of chondrosarcoma.
These results indicate that AR occurs through the Src/MEK/ERK/STAT-3 pathway, activating VEGF-C expression and contributing to lymphangiogenesis in human chondrosarcoma. Thus, AR could be a therapeutic target in metastasis and lymphangiogenesis of chondrosarcoma.
|Relation: ||CELLULAR PHYSIOLOGY AND BIOCHEMISTRY|
|Appears in Collections:||[生物科技學系] 期刊論文|
Files in This Item:
All items in ASIAIR are protected by copyright, with all rights reserved.